510(k) Report

510(k) · Cleared

Cleared

Total Protein Urine/CSF Gen.3

K141925510(k) SpecialCleared Dec 9, 2014146-day reviewClass I21 CFR 862.1645

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Operations (Rdo) · JIQ Turbidimetric Method, Protein Or Albumin (Urinary, Non-Quant.)

Cleared on Dec 9, 2014 as substantially equivalent to K071239 (Roche Diagnostics, 2007) after a 146-day review. Its family tree reaches back 2 generations to 1991.

Decided
Dec 9, 2014
Review
146 days
Class
Class I
Product code
JIQ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K913615 (1991). No later device cites it as a predicate yet.

  1. Root · 2 generations backK913615 Urinary/CSF ProteinBoehringer Mannheim Corp. · 1991
  2. 1 generation backK071239 Total Protein Urine/CSF Gen.3Roche Diagnostics · 2007
  3. This deviceK141925 Total Protein Urine/CSF Gen.3Roche Diagnostics Operations (Rdo) · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K913615Urinary/CSF ProteinBoehringer Mannheim Corp.1991—
−1K071239Total Protein Urine/CSF Gen.3Roche Diagnostics2007—
0 (this device)K141925Total Protein Urine/CSF Gen.3Roche Diagnostics Operations (Rdo)2014—
FIG. 1 — Lineage of K141925, 1991–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JIQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K071239Total Protein Urine/CSF Gen.3
Summary page 4
…ion of the predicate device. The device name, device TPUC3 Total Protein Urine/CSF Gen.3, is unchanged from how it was cleared in 510(k) K071239. Regulatory Table 1: Regulatory Classification of Candidate Device classification of Device Classification Name…
Roche Diagnostics2007—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 16.0 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All JIQ devices

JIQ Turbidimetric Method, Protein Or Albumin (Urinary, Non-Quant.): FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · JIQ

1in 2014

2014: 1
2007high 1 (2014) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JIQ

Too few JIQ 510(k)s in any year since 2007 to give a median.

Recalls per year · JIQ

1in 2012

2012: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JIQ

9in 2025

2011: 12023: 12024: 32025: 9
2007high 9 (2025) · low 0 (2007)2025

MAUDE reports naming product code JIQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—01
20120—10
20130—00
20141—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—01
20240—03
20250—09
20260—0—

What is it indicated for?

In vitro test for the quantitative determination of the total protein concentration in urine and cerebral spinal fluid.

Protein measurements in urine are used in the diagnosis and treatment of disease conditions such as renal or heart diseases, or thyroid disorders.

CSF protein measurements are used in the diagnosis and treatment of conditions such as meningitis, brain tumors, and infections of the central nervous systems.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K141925: Total Protein Urine/CSF Gen.3.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K141925

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026